Back
JPMorgan Active Value ETF Vs. Stoke Therapeutics, Inc. Industry Stock Comparison
Buy
56
JAVA
JPMorgan Active Value ETF
Last Price:
$72.60
Seasonality Move:
3.28%
Buy
69
STOK
Stoke Therapeutics, Inc.
Last Price:
$34.33
Seasonality Move:
1.4%
Buy
56
JPMorgan Active Value ETF (JAVA)
is a Buy
Is JPMorgan Active Value ETF a Buy, Sell or Hold?
-
The current JPMorgan Active Value ETF [JAVA] share price is $72.04. The Score for JAVA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
JAVA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Stoke Therapeutics, Inc. (STOK)
is a Buy
Is Stoke Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Stoke Therapeutics, Inc. [STOK] share price is $34.15. The Score for STOK is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
STOK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JAVA Stock Price Chart
What is JPMorgan Active Value ETF's stock price today?
-
The JPMorgan Active Value ETF share price today is $72.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JAVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
STOK Stock Price Chart
What is Stoke Therapeutics, Inc.'s stock price today?
-
The Stoke Therapeutics, Inc. share price today is $34.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing buying pressure, which is a positive indicator for future bullish movement.
JAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 64.3 | Buy |
| Chaikin Money Flow: | 223836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.04 - 71.3) | Buy |
| Bollinger Bands (100): | (66.8 - 70.08) | Buy |
STOK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.21 | Buy |
| Relative Strength Index (14 RSI): | 64.1 | Buy |
| Chaikin Money Flow: | 982663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.02 - 31.6) | Buy |
| Bollinger Bands (100): | (17.35 - 30.63) | Buy |
JAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.34 | Buy |
| 20-day SMA: | 70.29 | Buy |
| 50-day SMA: | 69.6 | Buy |
| 200-day SMA: | 65.9 | Buy |
| 8-day EMA: | 71.27 | Buy |
| 20-day EMA: | 70.59 | Buy |
| 50-day EMA: | 68.17 | Buy |
| 200-day EMA: | 42 | Buy |
STOK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.3 | Buy |
| 20-day SMA: | 29.6 | Buy |
| 50-day SMA: | 29.4 | Buy |
| 200-day SMA: | 16.74 | Buy |
| 8-day EMA: | 31.58 | Buy |
| 20-day EMA: | 30.19 | Buy |
| 50-day EMA: | 28.19 | Buy |
| 200-day EMA: | 20.01 | Buy |
JPMorgan Active Value ETF Earnings Growth & JAVA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Stoke Therapeutics, Inc. Earnings Growth & STOK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.07 per share, and a decrease next year of $3.13 per share.
JPMorgan Active Value ETF Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Stoke Therapeutics, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||